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118Objective: To explore the relationship between intraoperative regional cerebral oxygen saturation (rSO2) mea-
sured by near-infrared spectroscopy (NIRS) and neurodevelopmental outcome in children after cardiac surgery.
Methods: Cross-sectional neurodevelopmental evaluation at 2 years of age was performed in a cohort of
young infants who had surgery for congenital heart disease in 2007. The third edition of Bayley Scales of
Infant and Toddler Development (Bayley-III) was used to assess cognitive, language, and motor functioning.
Clinical and perioperative data were collected, including intraoperative rSO2 nadir, rSO2 percent decrease
from baseline, and cumulative minutes of at least 20%, 30%, and 40% decrease from baseline.
Results: Twenty-seven patients without chromosomal abnormality were included in analyses. Mean Bayley-III
scores fell within 1 standard deviation of the normative mean. Stepwise regression analyses of patient- and
procedure-related variables, including rSO2, demonstrated that cognitive ability was predicted by length of hos-
pital stay and premature birth (58.1% of variance), receptive communication was predicted by length of hospital
stay and rSO2 nadir (40.2% of variance), expressive communicationwas predicted by birthweight (26.2% of var-
iance), fine motor functioning was predicted by duration of cardiac intensive care unit stay (41.4% of variance),
and gross motor functioning was predicted by the presence of a significant comorbidity (43.5% of variance).
Conclusions: In a contemporary cohort of infants undergoing surgery for congenital heart disease, neurodeve-
lopmental outcomes at 2 years of age are largely influenced by patient-related characteristics. Although recep-
tive communication appears to be influenced by rSO2 nadir, the predictive value of NIRS remains unclear.
(J Thorac Cardiovasc Surg 2012;143:118-25)With the dramatic decline in mortality among children with
congenital heart disease (CHD), attention has been directed
toward functional outcomes. Neurodevelopmental impair-
ment is the most common morbidity among survivors
with CHD, limiting academic achievement, employability,
and overall quality of life.1 Intraoperative regional cerebral
oxygen saturation (rSO2) has been identified as a potential
contributor to neurodevelopmental outcomes among chil-
dren undergoing cardiac surgery.2 Monitoring of rSO2
with near-infrared spectroscopy (NIRS), a noninvasive op-
tical technique that monitors brain tissue oxygenation
through measurement of oxyhemoglobin and deoxyhemo-
globin concentrations, is gaining acceptance.3-5 However,
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The Journal of Thoracic and Cardiovascular Surgmethodologic limitations of previous studies, and a lack
of evidence correlating NIRS values with
neurodevelopmental scores or demonstrating that NIRS
data can be used to improve outcomes are commonly
cited as obstacles to embracing NIRS monitoring as
routine in pediatric cardiac surgery.6 Only a few published
reports examine the relationship between perioperative ox-
ygenation and later neurodevelopmental functioning,7-9
and unfortunately these studies have used inconsistent
methods and, commonly, very small sample sizes.
Therefore, the existing data cannot provide the necessary
confirmation about the usefulness of this tool. This study
seeks to examine the predictive value of NIRS by
evaluating the relationship between rSO2 data obtained
using intraoperative NIRS and neurodevelopmental
outcome at 2 years of age.METHODS
Participants and Study Design
The current investigation is a retrospective cross-sectional study exam-
ining the relationship between intraoperative rSO2 measured by NIRS and
neurodevelopmental outcome in young children with CHD. Participants
were 27 children without chromosomal abnormalities who underwent
surgery for CHD at our institution in 2007. All patients were under the
age of 12 months at the time of the operation and 24  3 months at the
time of study participation. Patients who were unable to undergo neurode-
velopmental testing or were non–English speaking were excluded fromery c January 2012
Abbreviations and Acronyms
Bayley-III ¼ Bayley Scales of Infant and Toddler
Development, Third Edition
CHD ¼ congenital heart disease
CICU ¼ cardiac intensive care unit
DHCA ¼ deep hypothermic circulatory arrest
NIRS ¼ near-infrared spectroscopy
PDI ¼ Psychomotor Development Index
rSO2 ¼ regional cerebral oxygen saturation
Simons et al Congenital Heart Disease
C
H
Denrollment. The Nemours Institutional Review Board approved the study,
and informed consent and parental permission were obtained from the par-
ents or legal guardians before study participation.
A total of 79 patients under the age of 12 months underwent open car-
diac operations for a cardiac defect using NIRS monitoring in 2007. There
were 62 English-speaking survivors at the time of study enrollment, and 43
of their families provided informed consent. Nineteen families did not con-
sent owing to factors such as family relocation or lack of interest. Of those
who did consent, 39 were tested. Twelve of the tested patients had a docu-
mented chromosomal abnormality and were excluded from the present
analyses, resulting in a final sample size of 27.
Operative Management
Patients were managed preoperatively and postoperatively in a dedi-
cated cardiac intensive care unit (CICU). Perfusion management included
pH-stat strategy during cooling with a target hematocrit value of 30%, as
well as fresh whole blood and a single dose of methylprednisolone in the
cardiopulmonary bypass prime. Deep hypothermic circulatory arrest
(DHCA) was used at the discretion of the surgeon. No variation in perfu-
sion practices or personnel occurred during the study period. Perioperative
management decisions were not made on the basis of NIRS data.
NIRS
Regional cerebral oxygenation with NIRS (INVOS 5100B; Somanetics,
Troy, Mich) was routinely recorded during surgery for CHD by placement
of a probe on the forehead in the midline position. The INVOS is a contin-
uous-wave near-infrared spectrometer that uses 2 wavelengths of light (730
and 810 nm) to measure the ratio of oxyhemoglobin to total hemoglobin to
derive oxygen saturation, the scale unit of which is percent. This informa-
tion was then used to calculate (1) the lowest saturation level during the op-
erative period (nadir), (2) the percent decrease from baseline to nadir, (3)
rSO2 nadir below 40%, 30%, and 20% (yes/no variables), (4) 20%,
30%, and 40% decrease from baseline (yes/no variables), and (5) cumula-
tive minutes at 20%, 30%, and 40% decrease from baseline. We examined
both absolute and relative measures of rSO2. In addition to comparing the
neurodevelopmental outcomes of patients above and below the levels sug-
gested to be associated with increased risk (rSO2 of 40% or 20% decrease
from baseline),5 comparison of patients falling above and below alternative
levels was performed given the lack of empirical data correlating any spe-
cific level with neurodevelopment outcomes. NIRS data were unavailable
for 1 participant; therefore, sample size was 26 for regression analyses in-
volving NIRS variables.
Neurodevelopmental Testing
Children were administered the Bayley Scales of Infant and Toddler
Development, Third Edition (Bayley-III)10 by a clinical psychologist ac-
cording to standardization. The Bayley-III assesses the developmental
functioning of infants and young children between the ages of 1 monthThe Journal of Thoracic and Caand 42 months through items administered to the child in a structured
play format. As compared with the Bayley-II, this updated measure allows
for the calculation of separate cognitive, receptive communication, and ex-
pressive communication scaled scores (previously combined into the
Bayley-II Mental Development Index) and separate fine motor and gross
motor scaled scores (previously combined into the Bayley-II Psychomotor
Development Index [PDI]). Scaled scores have a mean of 10 and a standard
deviation of 3. After the evaluation, families who expressed interest in ob-
taining feedback regarding the results of their child’s evaluation were pro-
vided with a brief verbal debriefing. We were able to obtain only partial
neurodevelopmental data for 7 of the 27 patients owing to child fussiness
or refusal to complete testing. All available data for these patients were in-
cluded in analyses.
Analytic Strategy
Exploratory univariable analyses assessed the relationships of patient-
and procedure-related characteristics and NIRS variables to neurodevelop-
mental scores. Procedure-related characteristics referred to the operation
with NIRS monitoring in 2007, with the exception of history of multiple
cardiac procedures, history of multiple procedures with DHCA, and cumu-
lative exposure to DHCA. Associations with sociodemographic variables
were also examined. For multivariable analysis, only those variables asso-
ciated with each neurodevelopmental outcome at P<.05 were considered
in forward stepwise regression analyses. The entry criterion was set at
P<.05 and the removal criterion was set at P  .10. Explained variance
for all models was calculated by adjusted R2 values.
To further examine the predictive value of NIRS on neurodevelopmental
outcome, we performed secondary analyses in which all patients were strat-
ified into 2 groups for each neurodevelopmental domain: delayed and non-
delayed. Patients were considered delayed if their score was more than 1
standard deviation below the normative mean. All other patients were con-
sidered nondelayed. Independent samples t test (for continuous variables)
and Fisher’s exact test (for dichotomous variables) were used to compare
the 2 groups.
The Nemours Foundation was not involved in data interpretation.RESULTS
Baseline Characteristics
Cardiac procedures for the 27 patients included in analy-
ses were Fontan or hemi-Fontan (n ¼ 6), arterial switch
(n ¼ 3), Ross-Konno (n ¼ 2), Norwood (n ¼ 2), orthotopic
heart transplantation (n¼ 2), and repair of a ventricular sep-
tal defect (n¼ 5), right ventricular outflow tract obstruction
(n¼ 3), tetralogy of Fallot (n ¼ 2), truncus (n ¼ 1), and co-
arctation/ventricular septal defect (n ¼ 1). Table 1 reports
patient- and procedure-related characteristics for these 27
patients and for the 16 eligible patients without chromo-
somal abnormalities who did not enroll or participate in
neurodevelopmental testing. Table 2 reports sociodemo-
graphic information for the study sample. Patients who
did not enroll or participate in testing were more likely to
be of an ethnic minority group than those who did partici-
pate in testing (56% vs 26%; P¼ .047). Table 3 reports de-
scriptive data for the NIRS variables in this sample.Neurodevelopmental Outcomes
Receptive communication (9.2  3.5), expressive
communication (9.5  3.4), and fine motor (9.3  3) de-
velopment were comparable with that of the generalrdiovascular Surgery c Volume 143, Number 1 119
TABLE 1. Patient-and procedure-related characteristics of tested and
nontested patients
Tested
(n ¼ 27)
Nontested
(n ¼ 16)
Median (1Q-3Q)
Birth weight (kg) 3.2 (2.6-3.3) 3.2 (2.3-3.5)
Age at operation (mo) 1.9 (1.0-5.0)y 4.5 (1.5-7.6)
Weight at operation (kg) 4.5 (3.5-5.8)y 5.6 (4.0-7.3)
Aristotle Complexity Score 11.5 (8.0-14.3) 9.9 (6.3-13.6)
Total CPB support (min) 82.5 (73-121) 80 (55.5-124.0)
DHCA (min) 39 (0-43) 38.5 (0-40.8)
CICU stay (d) 6 (2-15) 2.5 (1-12.0)
Hospital stay (d) 11 (8-22) 12.5 (6.3-65.3)
Cumulative exposure to
DHCA (min)
42 (38-85) 39.5 (3.8-62.8)
Frequency (%)
Premature birth (<37 wk) 3 (11.1%) 2 (12.5%)
Significant comorbidity* 9 (33.3%) 5 (31.3%)
Single-ventricle physiology 8 (29.6%) 3 (18.8%)
Preoperative CICU 10 (37.0%) 7 (43.8%)
Use of DHCA 19 (70.4%) 11 (68.8%)
Preoperative cyanosis 12 (44.4%) 8 (50.0%)
Multiple procedures (lifetime) 12 (44.4%) 9 (56.3%)
Multiple procedures with
DHCA (lifetime)
10 (37.0%) 3 (18.8%)
1Q, First quartile; 3Q, third quartile;CPB, cardiopulmonary bypass;DHCA, deep hy-
pothermic circulatory arrest; CICU, cardiac intensive care unit. *Significant comor-
bidities of tested participants included restrictive atrial septal defect, prematurity
(<35 weeks’ gestational age), arrhythmia, necrotizing enterocolitis, seizures, de-
pressed myocardial function, history of prolonged mechanical ventilation/portal hy-
pertension/pneumonia, protein-losing enteropathy/right ventricle dysfunction/
pacemaker. yP<.10.
TABLE 2. Sociodemographic variables for the study sample (n ¼ 27)
Variable Frequency (%)
Gender
Male 14 (51.9%)
Female 13 (48.1%)
Race/ethnicity
Nonhispanic white 20 (74.1%)
Black or African American 5 (18.5%)
Hispanic or latino 1 (3.7%)
Asian American 1 (3.7%)
Household income
<$39,999 10 (37.0%)
$40,000-$69,999 7 (25.9%)
$70,000-$99,999 7 (25.9%)
>$100,000 3 (11.1%)
Education level of accompanying parent
High school/GED/vocational 8 (29.6%)
Some college 7 (25.9%)
College degree 8 (29.6%)
Graduate degree 4 (14.8%)
Education level of spouse/partner (n ¼ 22)
High school/GED/vocational 6 (27.3%)
Some college 8 (36.4%)
College degree 6 (27.3%)
Graduate degree 2 (9.1%)
GED, General Educational Development.
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Dpopulation. Mean cognitive (8.2 3.3) and gross motor (8.1
 1.8) scores were significantly lower than published norms
(P<.05), although still within 1 standard deviation of the
normative mean (10  3). Figure 1 displays neurodevelop-
mental outcomes for the total sample, participants with
rSO2 nadir of 40% or more (n ¼ 21), and participants
with rSO2 nadir less than 40% (n ¼ 5).TABLE 3. NIRS variables (n ¼ 26)
Continuous variables Median (1Q-3Q)
rSO2 nadir 42.5 (40-49)
rSO2% decrease from baseline 32.7% (22.9-46.6%)
Minutes at 20% decrease from baseline 9.0 (2.5-38.5)
Minutes at 30% decrease from baseline 1.0 (0-29.5)
Minutes at 40% decrease from baseline 0 (0-8.0)
Categorical variables Frequency (%)
rSO2 nadir<40% 5 (19.2%)
rSO2 nadir<30% 4 (15.4%)
rSO2 nadir<20% 3 (11.5%)
Percentage decrease from baseline
20% 22 (84.6%)
30% 14 (53.8%)
40% 8 (30.8%)
NIRS, Near-infrared spectroscopy; 1Q, First quartile; 3Q, third quartile; rSO2, intra-
operative regional cerebral oxygen saturation.Predictors of Bayley-III Scores
Sociodemographic variables were not associated with
any of the neurodevelopmental domains in exploratory uni-
variable analyses and were therefore not subsequently con-
sidered in stepwise regression analyses. Neither
preoperative cyanosis nor postoperative cyanosis was sig-
nificantly associated with any of the neurodevelopmental
domains in exploratory univariable analyses, therefore not
meeting entry criterion for multivariable stepwise regres-
sion analyses. When postoperative cyanosis was forced
into the regression models, it continued to have nonsignifi-
cant relationships with all 5 neurodevelopmental domains
and did not affect which variables were included in each fi-
nal multivariable model. Table 4 reports final stepwise re-
gression models for each neurodevelopmental outcome.120 The Journal of Thoracic and Cardiovascular SurgCognitive. Premature birth, single-ventricle physiology,
presence of a significant comorbidity, age at operation,
length of stay in the pediatric CICU, length of hospital
stay, and history of multiple procedures with DHCA were
correlated with cognitive scores in univariable analyses.
None of the NIRS variables studied was associated with
cognitive scores. The final multivariable model included
length of hospital stay and premature birth and accounted
for 58.1% of the variability in cognitive outcome.ery c January 2012
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rSO2 ≥ 40 8.6 9.8 10.4 9.8 8.5 
rSO2<40 7.8 8.2 8.2 9.4 7.6 
Cog RC EC FM GM 
FIGURE 1. Neurodevelopmental outcomes of total sample (n¼ 27), rSO2
nadir 40 (n¼ 21), and rSO2 nadir<40 (N¼ 5). Note. Scores have a nor-
mative mean of 10 and standard deviation of 3. Cog, Cognitive; RC, recep-
tive communication; EC, expressive communication; FM, fine motor;GM,
gross motor.
TABLE 4. Final stepwise regression models
Neurodevelopmental
outcomes B SE (B) b P R2
Regression 1: Cognitive 0.58
Length of hospital stay .05 .01 .67 <.001
Premature birth 5.0 1.3 .48 .001
Regression 2: Receptive
communication
0.40
Length of hospital stay .03 .01 .53 .004
rSO2 nadir .11 .04 .44 .01
Regression 3: Expressive
communication
0.26
Birth weight 4.1 1.6 .56 .02
Regression 4: Fine motor 0.41
Duration of CICU stay .05 .01 .67 .001
Regression 5: Gross motor 0.44
Significant comorbidity 2.5 .63 .68 .001
SE, Standard error; rSO2, intraoperative regional cerebral oxygen saturation; CICU,
cardiac intensive care unit.
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DReceptive communication. Premature birth, presence of
a significant comorbidity, rSO2 nadir, and length of hospital
stay were correlated with receptive communication scores
in univariable analyses. The final multivariable model in-
cluded length of hospital stay and rSO2 nadir and accounted
for 40.2% of the variability in receptive communication
outcome.
Expressive communication. Birth weight and presence of
a significant comorbidity were correlated with expressive
communication scores in univariable analyses. None of
the NIRS variables studied was associated with expressive
communication. The final multivariable model included
birth weight and accounted for 26.2% of the variability in
expressive communication outcome.
Fine motor. Premature birth, presence of a significant co-
morbidity, a 20% decrease in rSO2 from baseline (yes/no
variable), duration of stay in the CICU, and length of hospi-
tal stay were correlated with motor scores in univariable
analyses. The final multivariable model included duration
of stay in the CICU and accounted for 41.4% of the vari-
ability in fine motor outcome.
Gross motor. Premature birth, presence of a significant co-
morbidity, history of multiple cardiac procedures, and cu-
mulative exposure to DHCA were correlated with gross
motor scores at P< .05 in univariable analyses. None of
the NIRS variables studied was associated with gross motor
scores. The final multivariable model included presence of
a significant comorbidity and accounted for 43.5% of the
variability in gross motor outcome.
Predictors of Developmental Delay
Patients were categorized as delayed (>1 standard devia-
tion below the normative mean) versus nondelayed with re-
gard to cognitive, receptive communication, expressive
communication, fine motor, and gross motor functioning.
Cognitive. Patients who exhibited delayed cognitive abili-
ties were more likely to have a significant comorbidity (4/5;The Journal of Thoracic and Ca80%) as compared with those without cognitive delays
(5/22; 23%) (P ¼ .03; Fisher’s exact test) and were more
likely to have multiple procedures with DHCA (4/5;
80%) as compared with those without cognitive delays
(6/22; 27%) (P ¼ .047; Fisher’s exact test).
Receptive communication. Patients who exhibited de-
layed receptive communication had an older age at
operation as compared with those without receptive com-
munication delays (t23 ¼ 2.2; P ¼ .04), and were more
likely to have a significant comorbidity (4/5; 80%) as com-
pared with those without receptive communication delays
(5/20; 25%) (P ¼ .04; Fisher’s exact test).
Expressive communication. Patients who exhibited de-
layed expressive communication were more likely to
have a significant comorbidity (4/4; 100%) as compared
with those without expressive communication delays (4/
18; 22%) (P ¼ .01; Fisher’s exact test) and were more
likely to have an rSO2 nadir of less than 20% saturation
(2/3; 67%) as compared with those without expressive
communication delays (1/18; 6%) (P ¼ .04; Fisher’s exact
test).
Fine motor. Patients who exhibited delayed fine motor
abilities were more likely to have been born prematurely
(2/3; 67%) as compared with those without fine motor de-
lays (1/19; 5%) (P ¼ .04; Fisher’s exact test) and were
more likely to have a significant comorbidity (3/3; 100%)
as compared with those without fine motor delays (5/19;
26%) (P ¼ .04; Fisher’s exact test).
Gross motor. Patients who exhibited delayed gross mo-
tor abilities had a longer duration of DHCA as compared
with those without gross motor delays (t18 ¼ 2.6;
P ¼ .02) and were more likely to have a significant co-
morbidity (4/4; 100%) as compared with those without
gross motor delays (3/16; 19%) (P ¼ .007; Fisher’s ex-
act test).rdiovascular Surgery c Volume 143, Number 1 121
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DDISCUSSION
Intraoperative rSO2 measured by NIRS was not a robust
predictor of neurodevelopmental outcomes in this sample
after accounting for patient- and procedure-related vari-
ables. Receptive communication, expressive communica-
tion, and fine motor performance were each associated
with a measure of rSO2 in univariable analyses; however,
only the relationship between rSO2 nadir and receptive com-
munication remained significant in multivariable analyses.
These results suggest that a given rSO2 may not have the
same impact on all neurodevelopmental domains. Whereas
intraoperative rSO2 as measured by NIRS may be a useful
predictor of later language abilities, it does not appear to
predict cognitive or motor sequelae at 2 years of age. It
should be noted that less variability across patients was
observed on gross motor tasks as compared with other
Bayley-IIIdomains and thenormative sample, andasagroup,
patients scored at the lower end of the normal range on the
gross motor domain. This domain may be more universally
affected in children with CHD who have undergone cardiac
surgery. Alternatively, given that the gross motor subtest is
typically administered last, poor performance on this subtest
may be a surrogate for the attentional difficulties that have
been previously documented in children with CHD.11
Despite the frequent use of DHCA in this patient cohort,
few children dropped below 40% rSO2. This is consistent
with other recent studies examining intraoperative rSO2.
8
The higher intraoperative rSO2 observed in this study could
be explained by the practice of limiting DHCA to a duration
of under 40 minutes whenever possible and using intermit-
tent reperfusion. It is possible that longer periods of DHCA,
associated with prolonged and more severe drops in rSO2,
may have revealed additional relationships between rSO2
and neurodevelopmental outcome.
The results of this study differ in some important ways
from the existing literature on rSO2 and neurodevelopmen-
tal outcome. Whereas we found that rSO2 was related to
later language development, Kussman and associates8 re-
ported a relationship between rSO2 and the Bayley-II PDI
only. Similarly, although Toet and colleagues9 did not find
a significant difference in neurodevelopmental outcome
above and below preoperative rSO2 values of 35%, a review
of the Bayley-II mean scores suggests that if there were
a difference, it would likely be specific to PDI. Although
Hoffman and associates7 reported a relationship between
low systemic mixed venous oxygen levels and neurodeve-
lopmental outcomes in children undergoing cardiac surgery,
therewas no direct relationship with NIRS data; poor neuro-
developmental outcomes in their patients may have been re-
lated to globally poor perfusion that may or may not be
evident in NIRS monitoring of rSO2.
Heretofore, studies of NIRS and neurodevelopmental
outcomes have been limited by the absence of other122 The Journal of Thoracic and Cardiovascular Surgimportant patient-related variables known to affect out-
come.1,12 For example, whereas Kussman and associates8
did adjust for age 30 days or less, diagnosis group, and so-
cial class, they did not consider other potentially important
variables such as premature birth, birth weight, and signif-
icant medical comorbidities. Without the inclusion of these
potential confounding variables, it is not clear whether rSO2
is an independent predictor of PDI scores.
Given a small number of studies directly examining
neurodevelopmental outcomes in relation to perioperative
oxygenation and varying methodologies, firm conclusions
cannot yet be drawn about the utility of rSO2 monitoring
for patients undergoing cardiac surgery. In addition, the
studies conducted thus far differ with regard to the neuro-
developmental testing battery, age at which children were
tested, underlying cardiac diagnoses of the study sample,
technology used to assess oxygenation, perioperative
phase during which rSO2 data were collected (preopera-
tive, intraoperative, or postoperative), and analytic tech-
niques. The ways in which rSO2 was measured and
defined also differ across studies and have included aver-
age or nadir rSO2, desaturation below a specified level,
and integrated rSO2 (minutes 3 desaturation points below
a specified level). To complicate matters further, the spec-
ified rSO2 level has not been consistent across studies and,
in some cases, has represented the median sample rSO2
rather than a cut point that optimally differentiates be-
tween children with and without delays. It will be impor-
tant for future studies to identify the rSO2 threshold that
may lead to neurodevelopmental delays and confirm the
predictive value of this monitoring tool in relation to spe-
cific domains.
Our data suggest that in a cohort of children undergoing
surgery for congenital heart defects during infancy,
patient-related characteristics, such as premature birth
and significant comorbidities, appear to be more robust
predictors of neurodevelopment than intraoperative rSO2.
Patient-related characteristics were also implicated when
patients exhibiting delay were compared with those with-
out delay on each neurodevelopmental domain. These find-
ings are consistent with prior research suggesting that
characteristics inherent to the child, present at birth, are
often important contributors to neurodevelopmental
delay.1,12 Also, as previously reported,13 length of stay in
the hospital and the CICU were associated with neurodeve-
lopmental outcomes, even after accounting for the effects
of potentially confounding patient- and procedure-related
characteristics. Length of stay is likely a surrogate variable
reflecting the influences of other factors affecting the cen-
tral nervous system and neurodevelopment. Young chil-
dren who experience a prolonged hospital stay are likely
sicker, prone to complications, and may be missing impor-
tant experiences and opportunities that would promoteery c January 2012
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Dtheir early development. Further research is necessary to
determine the mechanisms underlying this relation.
Limitations of this study include its small sample size and
the limited statistical power to detect true differences and
relationships. Given the interrelatedness of patient- and
procedure-related characteristics, large samples are needed
to determine which variables are driving observed effects.
Despite the frequent use of DHCA in this patient cohort,
few children had an rSO2 below 40 or a decrease from base-
line of 40% or more, resulting in limited statistical power to
compare children above and below the specified levels. Al-
though we had planned to also calculate cumulativeminutes
below 40%, 30%, and 20% saturation, these variables were
eliminated owing to the low number of participants whose
rSO2 dropped below the specified levels. It should be noted
that almost half of the participants in this study had multiple
operations and hospitalizations; therefore, whereas the pri-
mary focus of this study was on the specific operation dur-
ing which the patient received NIRS monitoring, it is
possible that events occurring during other operative proce-
dures affected neurodevelopmental outcomes at 24 months
of age. In addition, although neurodevelopmental outcomes
could be influenced by events at any time in the periopera-
tive period, NIRS values were only monitored during the
surgical procedure. Therefore, important events that may
have played a role in neurodevelopmental outcomes could
have gone undetected.
In conclusion, despite the intuitive appeal of rSO2 moni-
toring by NIRS during cardiac surgery, the predictive value
of NIRS for neurodevelopmental outcome remains unclear.
As suggested by these preliminary data, the predictive value
of NIRS may vary for different neurodevelopmental do-
mains, and it seems likely that this type of monitoring
may prove to be most useful in patients subjected to cyano-
sis, hemodynamic instability, and repeated interventions,
a population commonly perceived to be at highest risk for
neurodevelopmental impairment.
We thank Mrs Carol Prospero for her assistance in coordinating
this study.References
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Dr James S. Tweddell (Milwaukee, Wis).My thanks to the au-
thors for sending me their manuscript well in advance of this
meeting.
The authors have performed a prospective observational study
of infants less than 1 year of age looking for factors predicting neu-
rodevelopmental outcome and have included intraoperative NIRS
among those factors tested. They have found that the Bayley scores
were predicted by a large number of factors such as hospital length
of stay, prematurity, birth weight, length of stay in the cardiac in-
tensive care unit, and comorbidities. Only in the area of receptive
communication was the cerebral saturation found to be predictive.
Just for everyone’s benefit, could you explain to us what that par-
ticular domain, receptive communication, measures and its prog-
nostic importance?
Dr Sood. Absolutely. It measures receptive language—how
much language the child understands. Unlike expressive commu-
nication, we are not looking at what the child can actually commu-
nicate but instead what he or she understands. For example, a child
looks at a book of pictures and is asked to point to the ball, the toy,
the bear. Also, the child is observed interacting with the caregiver
and the examiner to see how well he or she responds. And your
next question refers to the predictive value?
Dr Tweddell. The prognostic significance.
Dr Sood.What we know is that, at 2 years of age, Bayley scores
do not correlate highly with later intelligence for most children.
The Bayley-III is a measure of development, rather than intelli-
gence. Intelligence is thought to be stable, whereas development
is characterized by spurts and lags. However, for children who
have known deficits, children who are below the average range,
the predictive value tends to be better. For these children, the Bay-
ley is more predictive of impairment later on in childhood and in
adulthood.
Dr Tweddell. Thank you. I want to emphasize here that the au-
thors have looked only at the intraoperative NIRS. The basicrdiovascular Surgery c Volume 143, Number 1 123
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mize or prevent cerebral ischemia that could result in neurologic
impairment. Certainly the operating room is one of those arenas
where that could occur, but it could also occur in other places, in
the case of neonates in the newborn nursery, and for all the patients
in the postoperative care unit. Patients can have a decrease in ce-
rebral oxygenation at any time during the hospitalization, and
any of those episodes could affect their neurodevelopmental out-
come. Particularly in this study, you identified events outside the
operating room, such as length of stay in the cardiac intensive
care unit and total hospital length of stay, as important factors.
Your study suggests that there might be other times when the pa-
tient is vulnerable.
Dr Sood. Absolutely.
Dr Tweddell. You also have included a heterogeneous popula-
tion, and this may be a strength or a weakness. In previous studies
in which NIRS was found to more strongly predict neurodevelop-
mental outcome, the patient populations studied were more uni-
form than in your study. In our own studies, we have included
primarily neonates with a single diagnosis, hypoplastic left heart
syndrome. In the recent publication from Boston, the study popu-
lation comprised patients undergoing 2-ventricle repair. In both
cases the study groups were fairly uniform, and perhaps that
improves the likelihood of identifying an impact of NIRS by min-
imizing the impact of confounding factors such as arterial satura-
tion and perfusion temperature.
How is the rSO2 nadir determined? Was that the lowest value?
Dr Sood. Yes, it was the lowest value during surgery.
Dr Tweddell. It was not the inflection point of the decay slope
or anything like that?
Dr Sood. Correct.
Dr Tweddell. Okay. How long did you have to stay at that level
before it became your nadir?
Dr Sood. You just had to reach that level.
DrTweddell.All right. Thank you.What constituted significant
comorbidities? Were there any neurologic injuries in that group?
Dr Sood. Comorbidities included restrictive atrial septal defect,
prematurity less than 35 weeks’ gestational age, arrhythmias, nec-
rotizing enterocolitis, seizures, depressed myocardial function,
history of prolonged mechanical ventilation, portal hypertension,
pneumonia, protein-losing enteropathy, right ventricular dysfunc-
tion, and pacemaker.
Dr Tweddell. Thank you. The seizures in particular could be
a neurodevelopmental outcome end point, too, couldn’t they?
You included both cyanotic and acyanotic children in your study,
and rSO2 is related to arterial saturation. How did you control or
account for that?
Dr Sood. We included preoperative cyanosis in univariable
analyses, and then we looked at what entered into stepwise regres-
sion analyses.
Dr Tweddell. Was that an anatomic diagnosis that determined
whether the child was cyanotic or was that a measure of arterial
saturation that determined cyanosis?
Dr Sood. That was a measure.
Dr Tweddell. Certainly if a child is profoundly cyanotic, the
rSO2 is going to be low as well, right? So it might be important
to control for that. I can certainly understand the drop to less
than 40% and the lowest value affecting neurodevelopmental124 The Journal of Thoracic and Cardiovascular Surgoutcome, but you found that a decrease to less than 20% of base-
line did not correlate with worse neurodevelopmental outcome.
Were those patients different in some way? Did they start off at
a higher baseline? Did you consider looking at or controlling for
baseline NIRS and how that correlated with outcome?
Dr Sood. This study did not focus on the baseline rSO2, but that
is certainly an area of future research.
Dr Tweddell. An rSO2 of 40% is a pretty widely accepted
threshold for cerebral ischemia at normothermia, but at deep hypo-
thermia it may not indicate adequate cerebral oxygenation. The
majority of your patients had DHCA. Did you do anything to con-
trol for temperature?
Dr Sood. We did not.
Dr Tweddell. The strengths of this paper include the measure-
ment of the potential benefit of NIRS as it is used in the typical
clinical situation with a broad spectrum of patients. Ultimately, I
think this analysis could benefit from the inclusion of NIRS data
from the entire hospitalization and controlling for differences in
baseline values, preoperative and postoperative cyanosis, and the
impact of deep hypothermia. This will be an important contribu-
tion and I thank you for allowing me to discuss it.
Dr Sood. Thank you.
Dr Pizarro. Bill, I just want to offer a couple explanations
about the methodology. One of the reasons we chose not to include
a specific patient population was that wewanted to try to discern, if
at all possible, what is the real contribution of NIRS into our deci-
sion making about how we conduct our clinical care in a real
world. I think that NIRS is being used in a number of institutions
across the board, not for monitoring of a specific subpatient pop-
ulation, but rather for everyone out there. So I think that the funda-
mental question was: How much do we learn from this insofar that
we could correlate with outcomes at least at 2 years of age? We
chose to use a most updated version of the Bayley scales that
will give us more domains to be tested and then try to discern
whether we could predict outcomes without making decisions
based on NIRS. I think the lesson is that, perhaps, if we would ex-
tend the limits of, for example, circulatory arrest, there would be
a far greater yield in trying to make predictions. For example,
100 minutes of circulatory arrest will definitely go along with
a very low value of NIRS and likely there will be a bad outcome.
But given what the current clinical practice is, we tried to learn
what the additional predictive value of NIRS is within the context
of standardized practice nowadays.
Dr J. William Gaynor (Philadelphia, Pa). I have a question
concerning management. Has this changed your practice? Do
you still record intraoperative NIRS? Do you act on intraoperative
NIRS? If not, why do you record it? Do you record NIRS in the
postoperative period and do you manage patients on the basis of
the postoperative NIRS? Has this changed your practice or what
you do at all?
Dr Pizarro. I will answer that. The answer is no, yes, no, and
no. That is, we continue to record as part of an ongoing study. I
think that we walked away from this learning and reaffirming
much of what your center and others have put forward, which is
the notion that there are many patient variables that really deter-
mine what the patients will look like when it comes to neurodeve-
lopmental testing later on. We are still accruing patients, including
intensive care unit stay NIRS, to have a far more in-depth analysis.ery c January 2012
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collection?
Dr Pizarro. Yes, we are doing it.
Dr Tweddell. Thank you.
DrConstantineMavroudis (Cleveland, Ohio).Was your ques-
tion intimating that this is a nice technology but maybe people do
not pay attention to it?
Dr Gaynor. I do not want to be the focus of the discussion.
Dr Mavroudis. But you already have been.
Dr Gaynor. There was a recent paper from Dean Andropoulos
at Texas Children’s where they used a very detailed neuromonitor-
ing program with transcranial Doppler sonography and NIRS in-
traoperatively, and they have a very detailed protocol to interact,
to respond to those changes. They have looked at preoperative
and postoperative brain magnetic resonance imaging. The mostThe Journal of Thoracic and Caimportant predictor of new injury was brain immaturity. None of
the NIRS variables that they measured correlated with outcome.
So my question is, will some centers actually use that number?
How is that number being used? If it is being recorded as part of
a research study, that’s one thing. If it is being recorded clinically
but not being acted on, that’s a different question.
Dr Mavroudis. My impression, and this is going to be anec-
dotal information on the basis of a worldwide survey, is that those
who use it will use it in the operating room. More than once I have
had a catheter in the wrong place, the anesthesiologist has alerted
me that the NIRS had fallen off, and I have adjusted the catheter. I
think we saved a significant problem there. So I think that the most
obvious answer to that question is, the information will be used in
the operating room. I rose to mention that because I suspect that
other people in the audience were thinking the same thing.rdiovascular Surgery c Volume 143, Number 1 125
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